SmartBinge: Smartphone Application for University Students With Binge Drinking Behavior

Sponsor
Centre Hospitalier Universitaire, Amiens (Other)
Overall Status
Recruiting
CT.gov ID
NCT06084832
Collaborator
EPSM Marne, Reims (Other), SCA-LAB UMR-CNRS 9193, Lille (Other), Paul Valery University, Montpellier (Other)
628
1
2
33
19

Study Details

Study Description

Brief Summary

Alcohol use is a causal factor in more than 200 diseases and injury conditions (see ICD-10) and in France, alcohol is the first cause of hospitalization. Binge drinking (BD) has emerged as a major public health issue among student populations and is associated with negative consequences and social, cognitive and brain alterations. More than half of French university students have reported BD in the past month and are at increased risk of several alcohol-related consequences such as memory and sleep impairments, and reduced quality of life. BD is also a major risk factor in the development of alcohol addiction, with individual and environmental factors playing a role that is still poorly understood. Moreover, most students and young adults are reluctant to seek interventions when it is provided by health care professionals (only 4-5%) and have poor insight with regard to their alcohol use patterns / habits. Thus, there is an urgent need for developing effective prevention and intervention programs to reduce alcohol drinking in students. Recent studies have demonstrated that new types of technology-delivered interventions are promising tools for addressing unhealthy alcohol use. For example, an uncontrolled trial pilot study using a smartphone application-delivered intervention produced a reduction in both number of drinks per week and BD from baseline to 3-month follow-up. A recent review also showed significant outcomes of a mobile health intervention for self-control of unhealthy alcohol use. The investigators hypothesize that a timeline follow-back and personalized feedback based on the use of a mobile application can reduce excessive alcohol intake at 3-months. This study will provide scientific knowledge about BD in students, but also regarding a new type of intervention that could be effective for prevention in non-treatment seeking individuals and reducing the severity of health problems associated with excessive alcohol intake.

Condition or Disease Intervention/Treatment Phase
  • Biological: blood microsampling
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
628 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Care Provider, Investigator)
Primary Purpose:
Prevention
Official Title:
Smartphone Application for University Students With Binge Drinking Behavior: National Randomized Controlled Trial
Actual Study Start Date :
Oct 1, 2023
Anticipated Primary Completion Date :
Apr 1, 2026
Anticipated Study Completion Date :
Jul 1, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: Binge Drinking

Biological: blood microsampling
blood microsampling for the measure of Phosphatidylethanol

Active Comparator: Binge Drinking-control

Biological: blood microsampling
blood microsampling for the measure of Phosphatidylethanol

Outcome Measures

Primary Outcome Measures

  1. Change of the number of standard drinks per week [30 months]

Secondary Outcome Measures

  1. Change of the PEth concentration [3 months]

    phosphatidylethanol (PEth)

  2. Change of the PEth concentration [6 months]

    phosphatidylethanol (PEth)

  3. Change of the PEth concentration [9 months]

    phosphatidylethanol (PEth)

  4. Change of the PEth concentration [12 months]

    phosphatidylethanol (PEth)

  5. Change of the PEth concentration [15 months]

    phosphatidylethanol (PEth)

  6. Change of the PEth concentration [18 months]

    phosphatidylethanol (PEth)

  7. Change of the PEth concentration [21 months]

    phosphatidylethanol (PEth)

  8. Change of the PEth concentration [24 months]

    phosphatidylethanol (PEth)

  9. Change of the PEth concentration [27 months]

    phosphatidylethanol (PEth)

  10. Change of the PEth concentration [30 months]

    phosphatidylethanol (PEth)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 25 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Students between 18 and 25 years old

  • AUQ score greater than or equal to 24, and AUDIT score greater than or equal to 3 for its first 3 items. Drinking details with the DDQ when necessary.

  • BD behavior: at least one occasion with 6 or more drinks in the last 3 months.

  • Consent to be included in the study

  • Affiliated to social security

Exclusion Criteria:
  • Not having a smartphone with an Apple or Android system.

  • Previous use of the MyDĂ©fi smartphone application

  • Declaration of a psychiatric / neurologic condition

  • Pregnant, parturient or breastfeeding woman

  • Subject under guardianship, curators or restricted under public law

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHU Amiens Picardie Amiens Picardie France 80054

Sponsors and Collaborators

  • Centre Hospitalier Universitaire, Amiens
  • EPSM Marne, Reims
  • SCA-LAB UMR-CNRS 9193, Lille
  • Paul Valery University, Montpellier

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier Universitaire, Amiens
ClinicalTrials.gov Identifier:
NCT06084832
Other Study ID Numbers:
  • PI2023_843_0069
First Posted:
Oct 16, 2023
Last Update Posted:
Oct 18, 2023
Last Verified:
Oct 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Centre Hospitalier Universitaire, Amiens
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 18, 2023